creating a
healthier future

DONATE NOW SUPPORT SCIENCE

News

26.03.17

Mónica Sousa wins the University of Porto’s Award for Excellence in Scientific Research

The i3S researcher was one of five selected from a field of 29 candidates.

26.03.13

Gilead GENESIS honours i3S researcher

Delfim Duarte has received funding to study new immunotherapy strategies for aggressive B-cell lymphomas, as part of a project involving i3S and IPO Porto.

26.03.09

The platform that will lead innovation in healthcare from the North has been launched

The Regional Platform for Smart Specialisation (PREI) in Life and Health Sciences, called Bridges4Health, was officially launched on the 3rd of March in Braga.

26.02.24

i3S scientists unravel genetic code associated with human diseases

A small sequence of mRNA involved in regulating gene activity and impacting neurological diseases and cancer may become a new therapeutic target.

26.02.24

Smart vascular prostheses recognised with innovation award

Researchers awarded for developing biomaterials that harness blood flow to power and monitor medical devices.

26.02.24

i3S researcher receives Edward Limbert Grant to investigate thyroid cancer

Elisabete Teixeira also won the Clinical Research Award for an oral presentation at the Portuguese Congress of Endocrinology 2026.

26.02.24

Researchers recognized for innovation in cellular immunotherapy

A research project by i3S researchers Salomé Pinho and Catarina Azevedo received funding to investigate a new treatment for solid tumours.

26.02.24

i3S secures five grants from the Portuguese League Against Cancer

Of the 16 scientific research grants in oncology awarded this year by the LPCC-NRN, five will support ongoing projects at i3S.

26.02.23

North Region creates platform to define innovation strategies in health

More than 30 institutions will come together on 3 March for the launch of the Regional Platform for Smart Specialisation in Life Sciences and Health - Bridges4Health.

Subscribe to our newsletter and keep up to date with our latest achievements.

Newsletter Subscription

Contacts
Status & Reports
Privacy Policy
Cookie Policy
Terms & Conditions
Whistleblower Channel